ARTELO BIOSCIENCES, INC. Investments, Fair Value Disclosure
ARTELO BIOSCIENCES, INC. (ARTL) had Investments, Fair Value Disclosure of $6.41 million as of 2024-12-31, per its 10-Q filed 2024-05-13.
Discontinued › Notes
us-gaap:InvestmentsFairValueDisclosure · last filed 2024-05-13
- 2024-12-31: Investments, Fair Value Disclosure $6.41M.
- 2023-12-31: Investments, Fair Value Disclosure $7.61M.
- 2023-09-30: Investments, Fair Value Disclosure $10.22M.
- 2023-06-30: Investments, Fair Value Disclosure $8.27M.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2024-12-31 | $6.41M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $7.61M 10-Q · filed 2024-05-13 |
| 2023-09-30 | $10.22M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.27M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $8.57M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $10.64M 10-K · filed 2024-03-25 |
| 2021-12-31 | $13.47M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |